- Home
- LEGN vs OBDC Comparison
LEGN vs OBDC Comparison
Compare LEGN & OBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LEGN | OBDC |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.8B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | LEGN | OBDC |
|---|---|---|
| Price | $19.07 | $10.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 9 |
| Target Price | ★ $63.08 | $14.28 |
| AVG Volume (30 Days) | 1.7M | ★ 6.8M |
| Earning Date | 01-01-0001 | 04-27-2026 |
| Dividend Yield | N/A | ★ 13.52% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.24 |
| Revenue | N/A | N/A |
| Revenue This Year | $46.27 | N/A |
| Revenue Next Year | $28.77 | N/A |
| P/E Ratio | ★ N/A | $9.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.24 | $10.70 |
| 52 Week High | $45.30 | $15.36 |
Technical Indicators
Market Signals| Indicator | LEGN | OBDC |
|---|---|---|
| Relative Strength Index (RSI) | 51.45 | 35.52 |
| Support Level | $17.46 | N/A |
| Resistance Level | $23.68 | $14.67 |
| Average True Range (ATR) | 0.95 | 0.38 |
| MACD | 0.22 | -0.02 |
| Stochastic Oscillator | 41.87 | 6.30 |
Price Performance
Historical ComparisonAbout LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About OBDC Blue Owl Capital Corporation
Blue Owl Capital Corp is a specialty finance company and business development company (BDC) focused on providing direct lending solutions to U.S. middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns, including senior secured, subordinated, or mezzanine loans and equity-related instruments. Its investment strategies are intended to generate favorable returns across credit cycles with an emphasis on preserving capital.